N
Google TrendGREEN CARD (500+) — Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:green card500+power outage near me10000+sony playstation1000+india2000+loki100+hubert hurkacz200+will shipley100+anthony mackie100+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Chimeric antigen receptor" (30 stories)

Top Headline Story

Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells
Lead StoryNaturegeneral
3d ago

Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aWHdQcGpBVHU0MFVRT2ZnYXUzeXNLbTU0QTA0cjJnem9MYS1ST3AxcUVfVmJPX0R5V0F5NV9TRkZBSUdCOHNMcDZ5SEd0cnVEaUI3SHh5S1RpZ1g1WWM4?oc=5" target="_blank">Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+20m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+20m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories
1000+20m ago

sony playstation

PS2 Discs Now Load on Jailbroken PS5 Consoles Through PS5SX2 Emulator

Filter stories
2000+20m ago

india

CJP Protest Live: 'Modi, as PM, is embarrassment to India' - Dipke's 1st reaction after being released

Filter stories

Search Results for "Chimeric antigen receptor"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis
CancerNetworkgeneral

Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNSXIzal9yV1lOMVd3b1hOcXJNTUZETDlBYXNXdGVUV05FQkMtby02S0RvdjhCX0labUIydWhwTm1yd0padS15MWNpNEtBUzJncHVDOFUyUUJRN3E4YW9hRnFyX3RnNFowSHJMQTZOSllXWjdxMGpYLUgtandsRUJYLWFMeEtzNXR4dzRienFnNUlGVE94UURXYWNfUkhESldxTWZvSW05V1dFRUpSSERz?oc=5" target="_blank">Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Chimeric Antigen Receptor T Cell Therapy Market To 2035: Earlier-Line Demand and Allogeneic Shift Drive Growth - News and Statistics
IndexBoxmarkets

Chimeric Antigen Receptor T Cell Therapy Market To 2035: Earlier-Line Demand and Allogeneic Shift Drive Growth - News and Statistics

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxQV0dZdUY3WXhTaHdydGZxS005QWtreVlmZm1TWVd2NXRoN0t1eU9QUXFjSTFrUEdYelBtYmMyV1RObUNiMlNGRGRtbzVRQVdHU1JQT3R3M0Z5UkN3dDg0SHdkbmJ4bVFkaWhHaFMwYmFxVnlvRXVMWDlPRWx5VGFIS3NNM2RZT0ljcUduNFo2aG9MRU5GZi1FT1ByWC1aMHZ5QTRYS29hVGFqR1hMYUpoclV3TFNpZkZiMHNBVE13S3JOX2p4N3Z3U0hUSG1FZktKUVJ4VG9icS1ZQ0tnRTAyVEowRUFlUDFCalJJ?oc=5" target="_blank">Chimeric Antigen Receptor T Cell Therapy Market To 2035: Earlier-Line Demand and Allogeneic Shift Drive Growth - News and Statistics</a>  <font color="#6f6f6f">IndexBox</font>

Read Full StoryMore like this
Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation
Wiley Online Librarygeneral

Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5ZSjA4SjZaQ01PNWJIWlFVTEpFUkxkY01TTks5bG5reVloTEQteVpUYm1kN1VKTnlyTEdvbzI2V24ySkxMZkJIcElCRGhDbDlVRDAtWDZ3Y1JIcS1zaWs3NnU4S2k2NlNDMlpj?oc=5" target="_blank">Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
Yahoo Financeworld

Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNNGVXMmtOaEFIRy1rN2dIc0VMTkJMV3BuRWhiTGdZNTJXSDhvb20wS3I3dndoYWRPU1BjU2RvWlFkR2t4QmJtN1V2bjNpcjZTY1hZZHZ3ZmJyenNHUFBkeGx2ekhma2tzU2JiQTQzWkc1ZU91Y254X3ZFZVp3MjRfXy0tdXFHQl9uaVdhQnJpX29SUGs4eFdtSzRzVXZpU21EZ2c?oc=5" target="_blank">Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
Fierce Biotechworld

UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNbFVrYUVOcmRMeDFtRnFna0lnb01jN2JXYmlhZjJUR2pHMFhJMnUyQVA5eGxnWUNzVnVyRzFibFVKLVJmd3ZqR3V4cDdnOWdpWnV4bGQtSW5uUTJHdEpDYy15WUtUQVdXU0I4RDMyVy1GcWIyN3N4Vmw3M2xzR3lqLURPSWowb0ZRaUFBdHN5V2xycF9fSmF1Vzg0NGowNzlKaEVmZFVvcFVPMjBP?oc=5" target="_blank">UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease
PNASgeneral

Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9Gcy1mSXFBUjR0UGszMWF4TS1nRnRrZDYtQmNzS3EzN1N4MXptUTRjbGdvUmVhRTFKR1ZjMll2TUpZZG1STmppempsdWJvSkYzWVRwdmpfY3dUT3Na?oc=5" target="_blank">Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease</a>  <font color="#6f6f6f">PNAS</font>

Read Full StoryMore like this
CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors
Frontiersgeneral

CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOLUpWU3k4c3YxZU5oLTlPTGlHcUlSRkVsN0QzRDZMS0ltVGEzQlBSY0VSRkFtX2dDWkNGWVhRZVpoWFo5N3JmU0JGYU1EUU5kOW1TMXppMUhyakk5ekpmUXZBcWM3TmhsUXptU3JCR1hzTHI0eFhrYWpnNFR0UHIzS1RkSjlyMmlmLWtpODNJWThxZw?oc=5" target="_blank">CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Expanding the Role of Immunotherapy in Lymphoma
Targeted Oncologyworld

Expanding the Role of Immunotherapy in Lymphoma

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPTm9uTXZCNjhwYXpKNmxSeGJfTG81NGZPbW9ORDB6aXdfYl9WVGRWQ2ZqRTJIV3gzYk5wR2NSS1VlR2Z2dW5fRVlabnFpWWVIUGpWcTlFNTJNWWJfdWZFbU1GWFdMSGtPbEc1TEhWSUJTRXBRRjY2Xy1HaHc4LUx4a0syN0h6TmM?oc=5" target="_blank">Expanding the Role of Immunotherapy in Lymphoma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
Science | AAAStech

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9Sb0YwOXlwekV1VUJJa1gtM0xONE5ZVGtBQjZ0Rjg0ZkIzT3h6TXB2enZFajc4NVl0Y1JRNGF4R2lWSFF4ZTBlQU1mdnJKNTJwRks1YXRLTzdnV0txdWJnQWx4LU9SVUk?oc=5" target="_blank">Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
Chimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review
Cureusworld

Chimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPLVdpQmg5UmdsOTlGbDZPblQ5dUNNNjdValdpamtRUUNXb016X0VsUzVHNzd0eWs4eTBOa0gyTndSOTdoc0tFU2hWU2FHTTJwUWxzVVJ6cVhhUy1YeUI3YXVlSlpCOEpMNU5jOUZ3R3ZwVzBMSFdyc2RfUVpfSjVBTHhCMXozLXhSUjVRb3czNVFvY0g3U0RaMWxOWXI2VjVyc3F4YjlpR2huakItOHBBTkJXMGM1R1pFUVJiNS1IbUowbjR4YWc?oc=5" target="_blank">Chimeric Antigen Receptor T-cell (CAR-T) Therapy in Autoimmune Diseases: A Narrative Review</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies
ASCO Publicationsgeneral

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE5BOWZybW1WbkZKeHVCUTNOb2NxYzVmR1VrWmNtZFBWYTEzWFpDNVVhR1FJeE9fbHZRZWlWNkp5bHl4Nm41U2hMUTRTbjdGT09Tb0ZyMDhfVVY?oc=5" target="_blank">Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies</a>  <font color="#6f6f6f">ASCO Publications</font>

Read Full StoryMore like this
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination
Naturegeneral

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqVFF6UFd4RjAyV3BCQVhxX0t3SWtMTlJMSDNiN0lWZ3NUYTJlY21lUnJLN296QUpnWENFQmtySnBKc01Uc1dDSmFkX2xBU0NSZGswOHpPV0tFQnFlX1Fn?oc=5" target="_blank">Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Weighing the Promise and Trade-offs of CAR NK Cell Therapy for Cancer
CancerNetworkgeneral

Weighing the Promise and Trade-offs of CAR NK Cell Therapy for Cancer

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQVHlEX2xkSnVOME1TTlpRcUJkMGY4ZG9jU1BKY0pVUDVHSS1wLUJkLVBSSzc5T0NLZGFHdzhFMnRlNGNwNUMyVndaQXJrNEkweVhsTlRQS1BPYVpteVZoMEZ5R3FTWWdkUUJhM2UyanpQNkJaRGI3ajlxMWpEbm9EVnkwQ01tNmtHbHc5WFZsM3pfZHM4YnBWNFhTV2hYYmxCeWhIZ1NCOA?oc=5" target="_blank">Weighing the Promise and Trade-offs of CAR NK Cell Therapy for Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases
Science Partner Journalsgeneral

Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAwYlJnZ0xqSHdhU3F5M3RQNUhxakhDeHVkTldnTGpMN3NlRzlFR1psYTNwdmdjT0hKSVg5YnVWSjhyLVJhdGp3RERIQjE1V3lRMm52SkdMckhXRWFxZ3RF?oc=5" target="_blank">Chimeric Antigen Receptor T Cells as Living Therapeutics Targeting Senescence and Age-Related Diseases</a>  <font color="#6f6f6f">Science Partner Journals</font>

Read Full StoryMore like this
Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumors
Frontiersgeneral

Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumors

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNa2ZTUUxYbGhVZ2VlYjdyVlhIa1pCOHRkamJJdEd0alVSN2FvQjcyUWYtQ0E2NUJXeF9rakYtbzI1OEQzSmJiRU1rWUo5b05ZampNVFhYblZTYjlGVkpDcExxY3VISUpXdzhnVEduVUlkXzBtdlB2ekk0dk9DWU5nTmloMDlibFpDaU9TVTI2cEotUQ?oc=5" target="_blank">Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumors</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains
Naturetech

Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBNLVRaeUh1N3NTMmtQcHpEOEo3MkVfUXRiYnRia09Ec2JVbTZESnI1RU5WSVAwY3F6d0pqWWdQal9yWFd2TUk4YmNncjdqXzlPRWE4SGdIeEw4VUxjUUNB?oc=5" target="_blank">Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
Naturegeneral

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9ZRjBDQ2xWY1lNNE5VTHNmVzdpZ3F6ancxZUs0OVdpaUE2T21TUUN4dDgtTWR3OU1ydEdNblhPR3FTNXNfa0R0WW56YjlkcDQwemRBeVcyU1VOOUZmd2tF?oc=5" target="_blank">Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Boosting CAR T cell efficacy in cancer with metabolic insights from design to diet
Naturegeneral

Boosting CAR T cell efficacy in cancer with metabolic insights from design to diet

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE55MExUcWdQUWRhS3YtTWp2aGJCZHBnWGUwbVBNcW1EM1NFSFdDcFA2QmpGdWNmcWc3M3gzUTcwTGNmLW1HeE9ZOE0wTWhYd1FLVGdYLTNlenlDR3lIUGtr?oc=5" target="_blank">Boosting CAR T cell efficacy in cancer with metabolic insights from design to diet</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications
Naturegeneral

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE8temdYaEhhZXNWZnE3OU9JdE9SM3NDY3d4dTRlU0ZSSG9BXzlkUjNWdWxGMEcwaWJES3JpdXdBX2RYZmpPcGl6SkJVUEl1Uk1pQkp5WmFGS3dsN1dJRjZv?oc=5" target="_blank">Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy
Science | AAASgeneral

Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBFYVRCWmpFS1h2aG5iVmVZT05FS1Y1TVNTNlVhWU1WRzNvN3MydmtsR1R6NV9GcjlXb0lGeVBrNUZwd01RWVFXbldVT29OUm5oamp0X1BEMnpJeEN4QVY0Tw?oc=5" target="_blank">Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib study
Naturegeneral

Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5mcm9zQjRSMVlUZTlodlB1aGJEWXNEWGRKbGJKcU9fbC00TFRDamVCZkxPbDBGTGZuNTJqY3JMSUFRX25ITUV6cWtQYWNFeUtyZ2Zsazc4d2hIMjRfaTZB?oc=5" target="_blank">Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility
Wiley Online Librarypolitics

Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE00eWxZVkZZSXBDUFhHZ1A0ZE9hWG1VeFpJM1RNT2ZqbDgyVXNlaUF1WmJoUDdYb0pEREJ4b0VIUmJ3OXZzWkJNQ29yeTkyTFRiNC1vb2Q3R3UxUEdnUTJ3MC1qZEVOSnJQdFN3YVVn?oc=5" target="_blank">Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells
Naturegeneral

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBsa2hEVkdDaXp5bUxXQ2NMTVZlbVUwa2Q4Zlk2SEpLZzNuOFBfQmFYQ21KSkJqOFJxOHNEay0yd0FvaWFuOXVMR0F5bHhBTmo5bWJzek1IcU9qOHl2UmJZ?oc=5" target="_blank">Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)—real world experience from the US multiple myeloma immunotherapy consortium |
Natureworld

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)—real world experience from the US multiple myeloma immunotherapy consortium |

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB3d2FLT0NXQnh0cUNEVFdnaEo5cnQ2c3ZjUTNQMmtfUnhDQ3oycW9hOHVNMHlUUmowMVVYUGRvZWV6cnMyS3NzcEVCM0UyQ0tuMmF3NkxFU3Q2MmJyWmRJ?oc=5" target="_blank">Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)—real world experience from the US multiple myeloma immunotherapy consortium |</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Weighing Safety vs Persistence With CAR NK Cell Therapy
CancerNetworkgeneral

Weighing Safety vs Persistence With CAR NK Cell Therapy

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQYkhVdWNXVlJReFNqRVdFQkxKeFRkYnFGWGU2dzFZTExqcWNxS0RVMUY1cFhjSVVkelB0Mk1PRkNoTVRZY0w1YjQtRWd0Q01uNldiVGFNalJURk1VN1VQVnhJRmtJQWNpZmU0NXRhcVF4aFlrbHh3cGJsTFBMRWVCcGNxMkJBX0RZYXFrRzE5bGpFWFVr?oc=5" target="_blank">Weighing Safety vs Persistence With CAR NK Cell Therapy</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Scalable stem cell method advances off-the-shelf CAR-T therapies
News-Medicalgeneral

Scalable stem cell method advances off-the-shelf CAR-T therapies

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOZHFpbnJhMnlhV3hSSG5iMml0NENjSzR3LXpwUWllOE9nTFdOQ2FWSDg3S3prei1vdVNxUXZJOXhuYW5peDR5aXR4ZUJZS3IyV0c4TDVPbDJVZGY2cUVhSENUMGRMM1RtRXowN2puVk4ybWw5TVhjRjNmZlNrdWYwalhmTUlPc0RXNFpGQzJpQUFVem1zejdfdXNzbzVDSS01MGJjRUhvc3RsamZ2bmtjemJR?oc=5" target="_blank">Scalable stem cell method advances off-the-shelf CAR-T therapies</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
Sweet-like syndrome secondary to chimeric antigen receptor T-cell therapy for multiple myeloma: a case report
Frontiersgeneral

Sweet-like syndrome secondary to chimeric antigen receptor T-cell therapy for multiple myeloma: a case report

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOWUFhb2VjLXVTZ2IxbDJRYXlQeGVIaG90LUpvd0w4VWtIVTFJM1pJOTFkX2JxREFyMXNud1M0SGx4YndUYVVhd01sQnZZVkY0UUFsZ0VtTnlRTU5ual9wNUFQX3dWbTBRS0JrREtCUXdPbDk1MnhEc0hVVFAzai1qcC0tMFdFVUhGYlllSExsTEtFQQ?oc=5" target="_blank">Sweet-like syndrome secondary to chimeric antigen receptor T-cell therapy for multiple myeloma: a case report</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma
Naturegeneral

Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1xdmlXeU51eS12YVpZR0M0eWlpSnliMTVDV0VtemNVdEtUUnd2X1pIaXc4d3plWXNLb244aUpXek1jMUhZdlJpTGVTdHpjOFU1MUVkNWVrNHU0UE5XVUQ0?oc=5" target="_blank">Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application
Frontiersgeneral

Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNNEgwY0gtT2g2OUdOSDlGX3JUeG9DbkExZFZ2OHZmZ3c0WV9qMGNxRTBfS2ZJMG1UTFVOWWdZSEpPeG84QnloTHhsblpYb0l1SkVrUzYyYWctdGYxcUpKSkVFQTE3ZS1kY2lfTHl2Z0V5dU5zajVEOTB6UWZZNWdqR0k4dlcwZll6ejZrclBR?oc=5" target="_blank">Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
"Chimeric antigen receptor" — Live Google News Trends & Headlines